One more case of bird flu in humans has been confirmed in China's Jiangsu province, health authorities said Saturday.

A 35-year-old woman surnamed Lu, who was confirmed to have the infection Saturday, is in critical condition, Xinhua quoted the local health department as saying.

Jiangsu has reported 7 human H7N9 cases so far this month.

China has reported more than 120 human H7N9 cases this year, including at least 39 deaths.

A woman who was born with Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome was recently implanted with a lab grown vagina and now leads a normal life.

The Mexican women who participated in the study said that she felt very fortunate because she could have a normal life, the New York Daily News reported.

She said that it is imperative to let other girls that have the same problem to know that there was a treatment and one could have a normal life.

The woman was 18-year-old when she had the procedure said that she was aware that she was the first one who got a vagina implanted.

MRKH is a syndrome where vagina is absent or underdeveloped.

In a significant finding, scientists at Johns Hopkins University have found a way to block abnormal cholesterol production, transport and breakdown, successfully preventing the development of atherosclerosis, the main cause of heart attacks and strokes and the number-one cause of death in humans.

The condition develops when fat builds inside blood vessels over time and renders them stiff, narrowed and hardened, greatly reducing their ability to feed oxygen-rich blood to the heart muscle and the brain.

The Johns Hopkins team published their study in the journal Circulation on April 7. Researchers said that it had identified and halted the fat and sugar molecule called glycosphingolipid (GSL), responsible for a range of biological glitches, from producing abnormal cholesterol.

In the study, the team used an existing man-made compound called D-PDMP to block the GSL molecule and found that the process prevented the development of heart disease in the experimental mice and rabbits who were fed a high-fat and high-cholesterol diet.

The findings reveal that D-PDMP appears to work by interfering with a constellation of genetic pathways that regulate fat metabolism on multiple fronts. From the way cells derive and absorb cholesterol from food, to the way cholesterol is transported to tissues and organs and is then broken down by the liver and excreted from the body.

"Atherosclerosis is a multi-factorial problem that requires hitting the abnormal cholesterol cycle at many points. By inhibiting the synthesis of GSL, we believe we have achieved exactly that," said the study's lead investigator Subroto Chatterjee, Ph.D., in a news release.

A new study has found that ginseng can help treat and prevent influenza and respiratory syncytial virus (RSV), a respiratory virus that infects the lungs and breathing passages.

In a recent issue of Nutrients and an upcoming publication of the International Journal of Molecular Medicine, Sang-Moo Kang reports the beneficial effects of ginseng, a well-known herbal medicine, on human health.

Kang's primary research focuses on designing and developing effective vaccines against viral diseases such as influenza virus and RSV, but he partnered with a university and research institutes in South Korea that wanted international collaborative projects to study if ginseng can be used to improve health and protect against disease because of the potential benefit in fighting these viruses.

Ginseng has been reported to have anticancer, anti-inflammatory and immune modifying abilities.

Seasonal influenza is a serious respiratory disease that causes annual epidemics in humans worldwide, resulting in about three to five million cases of severe illness and about 250,000 to 500,000 deaths, according to the World Health Organization. Influenza can spread quickly, and new, unexpected pandemic influenza viruses may emerge at any time and cross over to different species. The H1N1 influenza virus, a new strain known as swine flu that emerged in 2009, spread rapidly to more than 74 countries. There are also challenges with existing influenza vaccines, such as required annual updates and no protection against pandemic strains and bird flu.

In addition, there are no vaccines available for RSV , which affects millions and is the leading cause of inflammatory bronchiolitis pneumonia and viral death in infants and in some elderly adults.

In his study published in Nutrients, Kang investigated whether red ginseng extract has preventive effects on influenza A virus infection.

He found that red ginseng extract improves the survival of human lung epithelial cells infected with influenza virus. Also, treatment with red ginseng extract reduced the expression of genes that cause inflammation.

Researchers have claimed that the use of the probiotic L reuteri for infant colic does not reduce crying or fussing in infants nor is it effective in improving infant sleep, functioning or quality of life.

Joel Lavine, M.D., Ph.D., professor of pediatrics and chief of pediatric gastroenterology, hepatology and nutrition at Columbia University Medical Center, said the role of different intestinal microbes in producing or alleviating colic remains a subject of interest.

He said some studies have identified changes in the colonization that are associated with colic, although these changes have not been shown to be causative, and the specific kinds of bacteria potentially responsible have not been identified. Thus far, manipulation of gut colonization by probiotics remains an inexact science and conflicting evidence exists regarding the efficacy of probiotics in improving the problem.

Dr Lavine said manipulation of bacterial populations in the gut may reduce the amount of gas produced by virtue of reducing lactose malabsorption, adding that this problem of lactose malabsorption can be easily resolved by providing lactase to infants who are lacking, by way of commercially available infant drops.

The study has been published in the British Medical Journal.